Suzuken Co., Ltd. (9987)

Name: Suzuken Co., Ltd. (9987) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Healthcare · Wall Street (EE. UU.) · Última actualización: 2026-09-20

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, Specialty Drug Contract Distribution, and Healthcare Related Services.

Cifras clave

Capitalización bursátil: JPY 351 billion
Ingresos (ejercicio cerrado en 2026-03-31): JPY 2.49T
Beneficio neto: JPY 38.1B
Margen bruto: 7.7%
Margen neto: 1.5%

Ver gráficos interactivos y estados completos → Modelo de valoración (DCF) →

Cuenta de resultados anual

Cuenta de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Ingresos totales	JPY 2.49T	JPY 2.40T	JPY 2.39T	JPY 2.31T
Beneficio bruto	JPY 192.5B	JPY 192.2B	JPY 185.2B	JPY 179.7B
Ingresos operativos (EBIT)	JPY 36.4B	JPY 37.1B	JPY 34.9B	JPY 32.6B
Ingresos netos	JPY 38.1B	JPY 34.5B	JPY 29.0B	JPY 20.3B

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de 9987. /companies/us/9987

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.